OC-7 A SVR to post-LT antiviral treatment improves long-term survival in patients with genotype 1 HCV recurrence: An 'AISF RECOLT-C' Group Study

MLA

F.R. Ponziani, et al. “OC-7 A SVR to Post-LT Antiviral Treatment Improves Long-Term Survival in Patients with Genotype 1 HCV Recurrence: An ‘AISF RECOLT-C’ Group Study.” Digestive and Liver Disease, vol. 43, Feb. 2011, p. S67. EBSCOhost, https://doi.org/10.1016/s1590-8658(11)60008-x.

APA

F.R. Ponziani, A. Milani, A. Gasbarrini, R. Viganò, R.M. Iemmolo, M.F. Donato, M. Rendina, P. Toniutto, L. Pasulo, M. Cescon, E. De Martin, L. Miglioresi, V. Giannelli, D. Di Paolo, S. Agnes, S. Fagiuoli, & M. Pompili. (2011). OC-7 A SVR to post-LT antiviral treatment improves long-term survival in patients with genotype 1 HCV recurrence: An “AISF RECOLT-C” Group Study. Digestive and Liver Disease, 43, S67. https://doi.org/10.1016/s1590-8658(11)60008-x

Chicago

F.R. Ponziani, A. Milani, A. Gasbarrini, R. Viganò, R.M. Iemmolo, M.F. Donato, M. Rendina, et al. 2011. “OC-7 A SVR to Post-LT Antiviral Treatment Improves Long-Term Survival in Patients with Genotype 1 HCV Recurrence: An ‘AISF RECOLT-C’ Group Study.” Digestive and Liver Disease 43 (February): S67. doi:10.1016/s1590-8658(11)60008-x.